More serious concerns include: Acute pancreatitis : If severe, persistent abdominal pain occurs, possibly radiating to the back, with or without vomiting, treatment should be discontinued immediately and urgent medical attention sought Gallbladder disease : GLP-1 medications and weight loss can increase the risk of gallstones and cholecystitis
More than the weight loss, I feel better overall
Our previous articles, Alert: Tirzepatide No Longer on FDAs Drug Shortage List and Alert: Tirzepatide and Semaglutide Still on the Drug Shortage List, provide valuable insights into the evolving situation and the steps taken to address the shortages
Clinical response and tolerability guide progression
GLP-1 receptor agonists bind to GLP-1 receptors throughout the body, triggering several beneficial effects
Ask your healthcare provider questions about drinking and surgery